Physician profile
Karolina Borodo
NPI 1851586770
$4,385.59
in general payments reported to CMS, 2019-2025
49 companies · $697 in 2025
The $697 reported for 2025 was more than what 87% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $453 · 2020: $241 · 2021: $703 · 2022: $662 · 2023: $848 · 2024: $781 · 2025: $697.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,236 · Education: $90.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,235.65 |
| Education | $90.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $534.53 | 2023-2025 | Veozah |
| Abbvie INC. | $508.07 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Hologic Sales and Service, LLC | $421.47 | 2019-2025 | Acessa Provu System, Aptima, Thinprep 2000 Processor |
| Myovant Sciences INC. | $247.42 | 2021-2022 | |
| Daiichi Sankyo INC. | $192.53 | 2020-2023 | Injectafer |
| Sage Therapeutics, LLC | $169.50 | 2021-2025 | Zurzuvae |
| Pfizer INC. | $159.26 | 2021-2024 | |
| Millicent US INC | $150.34 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Myriad Women'S Health, INC. | $115.30 | 2023 | Myrisk |
| Bayer Healthcare Pharmaceuticals INC. | $105.98 | 2019-2024 | |
| Coopersurgical, INC. | $102.02 | 2021-2025 | Paragard T 380a, Mara Console, Ally II Ups |
| Organon LLC | $98.22 | 2022-2025 | Nexplanon, Jada System |
| Sumitomo Pharma America, INC. | $97.90 | 2023-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $97.64 | 2021-2024 | |
| Evofem Biosciences, INC. | $88.83 | 2021-2022 |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $82.46 | 2019-2022 | |
| Agile Therapeutics, INC. | $80.12 | 2021-2023 | Twirla |
| Exeltis, USA INC. | $69.75 | 2021-2025 | Slynd |
| Radius Health, INC. | $66.60 | 2022-2023 | Tymlos |
| Amgen INC. | $60.68 | 2022-2025 | Evenity, Prolia |
| Baxter Healthcare | $59.47 | 2023 | Tisseel |
| Merck Sharp & Dohme LLC | $57.16 | 2019-2025 | Gardasil 9 |
| Vertical Pharmaceuticals, LLC | $54.10 | 2019 | |
| Mylan Pharmaceuticals INC. | $54.04 | 2020-2022 | |
| Allergan, INC. | $49.89 | 2019-2020 | |
| Lupin INC. | $49.07 | 2019-2020 | |
| Meditrina | $46.64 | 2023-2024 | |
| Dysis Medical, INC. | $44.71 | 2020 | |
| Monaghan Medical Corporation | $43.09 | 2023-2024 | Aeroeclipse, Aerochamber |
| Ethicon US, LLC | $41.71 | 2025 | Vistaseal |
| Biohaven Pharmaceuticals, INC. | $39.10 | 2021 | |
| Coloplast Corp | $37.67 | 2021-2025 | |
| Channel Medsystems, INC. | $37.45 | 2023-2025 | |
| Medtronic, INC. | $33.33 | 2023 | Intellis Adaptivestim |
| Medicem INC. | $30.05 | 2021 | |
| Covidien LP | $29.05 | 2019 | |
| Avion Pharmaceuticals | $28.22 | 2019-2023 | Balcoltra |
| Duchesnay USA Incorporated | $24.39 | 2019 | |
| Abbott Laboratories | $21.60 | 2023 | Freestyle Libre 3 |
| Optumhealth Care Solutions, LLC | $19.72 | 2025 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Northgate Technologies, INC. | $18.46 | 2024 | Smoke Removal -Nebulae Srs |
| Aspira Women'S Health INC | $17.77 | 2021 | |
| Roche Diagnostics Corporation | $16.98 | 2021 | |
| Currax Pharmaceuticals LLC | $15.93 | 2024 | Contrave |
| Ascend Therapeutics US, LLC | $14.97 | 2024 | |
| Boston Scientific Corporation | $14.03 | 2023 | |
| Radiometer America, INC | $13.19 | 2021 | |
| Vyne Pharmaceuticals INC. | $12.84 | 2020 | |
| Smith+Nephew, INC. | $12.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karolina Borodo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.